Company / Cash per Share
Silence Therapeutics plc Cash per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.08
FY2025
5-year range
$0.08 / $1.13
FY2024-FY2025
Trend
-92.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
0.08 in FY2025.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 92.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -22.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.08 | -92.9% |
| FY2024 | $1.13 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026